An Open Label, Prospective, Non-Comparative Study to Evaluate Flexible Dose of Paliperidone Extended Release and Clinical Response in the Treatment of Subjects With Schizophrenia.
Phase of Trial: Phase IV
Latest Information Update: 02 May 2014
At a glance
- Drugs Paliperidone (Primary)
- Indications Schizophrenia
- Focus Therapeutic Use
- Acronyms PANDORA
- Sponsors Janssen
- 10 Jun 2017 Biomarkers information updated
- 23 Jun 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 23 Jun 2011 Actual end date (Jul 2010) added as reported by ClinicalTrials.gov.